Markets & Stocks
Stay informed about the latest developments and trends in the cannabis stock market with Business of Cannabis. Discover new investment opportunities, market analysis, and more in our stocks category.
Markets & Stocks · page 24
- Markets & Stocks
EU Cannabis Stocks Review: Stenocare Enters UK, Cellular Goods’ Sales Disappoint & Ukraine Crisis Hammers Stocks
The tragic developments in Ukraine hit global markets hard last week, and cannabis stocks even harder.
- Pharmaceutical
EU Cannabis Stocks Review: OCT’s Co-Founder Demands Removal Of All 6 Directors – More from Akanda, MGC Pharmaceuticals & Apollon
We start this week’s EU Cannabis Stocks Review with some breaking news from Oxford Cannabinoid Technologies, after the company’s co-founder calls for a general meeting in an attempt enact a dramatic management overhaul.
- Adult-Use
Cannabis beverages on the upswing
CANNA-THIRSTY Jones Soda and Monster want to ride the cannabis drinks wave Cannabis drinks were one of the fastest-growing cannabis categories last year, according to Headset, selling more than $64 million in California alone, reports Forbes.
- Adult-Use
EU Cannabis Stocks Review: Intercure Up 10% Amid Positive News From Israel, Ananda’s Progress Met With Share Dip, More From Cannovum, Chill Brands & Yooma Wellness
As markets across Europe continue to be hammered by international tensions, gas price increases and a looming cost of living crisis, cannabis stocks largely struggled to make any significant gains.
- Markets & Stocks
The great canna-bounce back?
THEN BEFORE AND NOW ONCE MORE Cannabis ETFs bounce back Canopy Growth’s latest earnings report, recent M&As and SAFE Banking’s re-emergence are being credited for helping cannabis ETFs make a comeback in the last week or so, reports CNBC.
- Hemp Industry
As Gordon Ramsay says, “Shut it down!” in New York
CLOSE…OR ELSE New York’s unlicensed dispensaries warned to close Cannabis shops suspected of participating in “illegal gifting” of THC products pre-legalized sales in New York have received cease-and-desist letters from the State’s Office of Cannabis Management, reports Cannabis Business Times.
- Pharmaceutical
EU Cannabis Stocks Review: Love Hemp jumps 60%, OCT sees recovery & more from Cellular Goods, Chill Brands and MGC Pharma
On the 1-year anniversary of the first cannabis company to list on the London Stock Exchange, we examine the reaction to a number of significant announcements from some of the UK’s biggest cannabis players, making for an eventful week in the markets.
- Adult-Use
Ok for your watch party, but no for a big game ad
THC-FREE NFL Weedmaps ad pleads for less censorship, more direct discourse In a new ad spot by Weedmaps, Brock Ollie—a life-size head of broccoli—can’t catch a break.
- Pharmaceutical
Cannabis M&A, lounging in the future and an LSE downturn
Ripe for the Picking | Cannabis M&A predictions for 2022 Low stock prices are likely to motivate more cannabis mergers and acquisitions in 2022, reports Insider.
- Pharmaceutical
London Stock Exchange Cannabis Company Values Down Almost £200m From Early Peaks
THIS has been a transformative year for the European cannabis industry, with growing liberalisation across the continent opening the floodgates for patients and investors alike.
- CBD Market
Cellular Goods Appoints New CEO As It Launches First Products Following £3m Loss
CELLULAR Goods has announced that health and beauty industry veteran Anna Chokina has replaced Alexis Abraham as its new CEO with immediate effect.
